Granahan Investment Management - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 105 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2023$6,186,354
-18.1%
574,940
+14.0%
0.19%
-18.6%
Q4 2022$7,552,811
+6.5%
504,193
-8.7%
0.23%
-0.4%
Q3 2022$7,092,000
+74.3%
552,350
+31.5%
0.23%
+66.9%
Q2 2022$4,070,000
-44.8%
419,995
-43.4%
0.14%
-24.0%
Q1 2022$7,377,000
+4.5%
742,158
+23.8%
0.18%
+26.2%
Q4 2021$7,056,000
+52.7%
599,522
+47.7%
0.14%
+64.8%
Q3 2021$4,622,000405,8340.09%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 600,000$6,456,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 450,283$4,845,0450.81%
Rubric Capital Management LP 2,775,636$29,865,8430.77%
AlphaCentric Advisors LLC 82,500$887,7000.61%
Parkman Healthcare Partners LLC 250,257$2,692,7650.59%
Lion Point Capital, LP 113,540$1,221,6900.50%
RICE HALL JAMES & ASSOCIATES, LLC 655,656$7,054,8590.40%
Jackson Creek Investment Advisors LLC 61,599$6630.28%
Tejara Capital Ltd 48,500$521,8600.27%
Birchview Capital, LP 30,000$3230.25%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders